Cyclodextrins as non-viral vectors in cancer theranostics: A review.

Clicks: 73
ID: 282913
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #193 of 200 articles by views in International journal of biological macromolecules

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 200 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Cancer ranks as the top cause of death following cardiovascular diseases. Identifying cancer patients at early stages presents significant challenges due to the asymptomatic nature of early-stage tumors. Conversely, the advancement of therapy resistance has led to a reduction in cancer treatment efficacy. Consequently, utilizing nanoparticles for the diagnosis and treatment of cancer can greatly enhance the prognosis and results for patients. CDs are recognized entities in the pharmaceutical domain and have been extensively used for therapeutic purposes in disease treatment. These non-viral vectors have shown efficacy in inhibiting both solid tumors and hematological malignancies through targeted drug delivery. CDs can enhance the administration of medications and genes in cancer treatment by ensuring their continuous release. The stimuli-responsive CDs have enhanced the targeted delivery of payloads at the tumor location, responding to the stimuli in TME such as pH, redox and light. CDs can serve as effective carriers that enhance the efficacy of phototherapy by improving the solubility and delivery of phototherapeutic agents, enabling integration with chemotherapy and immunotherapy. The administration of immunomodulators through CDs can enhance cancer immunotherapy and boost the infiltration of immune cells. Ultimately, CDs can aid in cancer diagnosis and the identification of biomarkers.
Reference Key
qu2025cyclodextrins Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Qu, Ge; Han, Xu; Ma, Lianghua; Feng, Shuai; Li, Yinyan; Zhang, Xue
Journal International journal of biological macromolecules
Year 2025
DOI
10.1016/j.ijbiomac.2025.143697
URL
Keywords
Cancer cyclodextrins carbohydrate polymers

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.